Yayınlar & Eserler

Yayın Ağı
Makaleler 13
Tümü (13)
SCI-E, SSCI, AHCI (13)
SCI-E, SSCI, AHCI, ESCI (13)
Scopus (13)

1. Comparison of Azathioprine-Induced Pancreatitis and Gastrointestinal Intolerance in IBD: Role of Demographics, Clinical Variables, and HLA DQA1/DRB1 Alleles

EŞKAZAN T., Bakkaloglu O. K., TÖRÜNER M., KANİ H. T., Cavus B., YILMAZ V., et al.
Journal of Clinical Medicine , cilt.14, sa.23, 2025 (SCI-Expanded, Scopus) identifier identifier identifier identifier

2. Histological disease progression in patients with metabolic dysfunction-associated steatotic liver disease using paired liver biopsy.

Turan Gokce D., Ekelik M., Gumussoy M., Kiremitci S., Bodakci E., Yilmaz V., et al.
European journal of gastroenterology & hepatology , 2025 (SCI-Expanded, Scopus) identifier

3. Comaparison of Effectiveness and Perisitence Anti-TNF drugs on Perianal Fistulizing Crohn's Disease: A Single Tertiary IBD Referral Center Experience

Koc O., Acehan M. F., Yilmaz V., Guvenir S. T., Toruner M.
JOURNAL OF CROHNS & COLITIS , 2025 (SCI-Expanded, Scopus) identifier

4. Delayed Diagnosis in Inflammatory Bowel Disease in Turkish Population

Acehan M. F., Yilmaz V., Koc O., Guvenir S. T., Er R. E., Soykan A., et al.
JOURNAL OF CROHNS & COLITIS , 2025 (SCI-Expanded, Scopus) identifier

5. The Effect of Extraintestinal Manifestations Presence on Treatment Persistence in IBD Treatment

Koc O., Eroglu Z., Yilmaz V., Acehan M. F., Guvenir S. T., Toruner M.
JOURNAL OF CROHNS & COLITIS , 2025 (SCI-Expanded, Scopus) identifier

6. Comparison of vedolizumab and ustekinumab treatment persistence in anti-TNF experienced perianal Crohn's Disease patients: A Single Center Experience

Eroglu Z., Acehan M. F., Koc O., Yilmaz V., Toruner M.
JOURNAL OF CROHNS & COLITIS , 2025 (SCI-Expanded, Scopus) identifier

7. Comparison of AZA-Related Pancreatitis and AZA-Related GI Intolerance Based on Demographic Factors, Clinical Variables and HLA DQA1/DRB1 Alleles

Eskazan T., Bakkaloglu O. K., Toruner M., KANİ H. T., Cavus B., Yilmaz V., et al.
JOURNAL OF CROHNS & COLITIS , 2025 (SCI-Expanded, Scopus) identifier

8. HEPATIC STEATOSIS IS ASSOCIATED WITH HBSAG CLEARANCE IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION

BODAKÇİ E., KİREMİTCİ S., DUMAN S., MELEKOĞLU ELLİK Z., Gumussoy M., GÜVENİR S. T., et al.
HEPATOLOGY , 2024 (SCI-Expanded, Scopus) identifier

9. Recurrence of primary sclerosing cholangitis after living donor liver transplantation: experience from turkish registry

Adali G., Harputluoglu M., Kayhan M. A., Gokce D. T., AKARSU M., Daniscomma N., et al.
JOURNAL OF HEPATOLOGY , 2024 (SCI-Expanded, Scopus) identifier

10. Histological and clinical disease progression in patients with metabolic dysfunction-associated steatotic liver disease using paired liver biopsy

Ekelik M., Gökçe D. T., Gumussoy M., Kiremitçi S., Bodakçi E., Yılmaz V., et al.
JOURNAL OF HEPATOLOGY , cilt.80, ss.479, 2024 (SCI-Expanded, Scopus) identifier

11. Histological and clinical disease progression in patients with metabolic dysfunction-associated steatotic liver disease using paired liver biopsy

Ekelik M., Gokce D. T., Gumussoy M., KİREMİTCİ S., Bodakci E., Yilmaz V., et al.
JOURNAL OF HEPATOLOGY , 2024 (SCI-Expanded, Scopus) identifier

12. DISEASE PROGRESSION IN PATIENTS WITH METABOLIC DYSFUNCTIONASSOCIATED STEATOTIC LIVER DISEASE USING PAIRED LIVER BIOPSY

Turan D., Ekelik M. M., Gumussoy M., Kiremitci S., Bodakci E., Yilmaz V., et al.
GASTROENTEROLOGY , cilt.166, sa.5, ss.1642, 2024 (SCI-Expanded, Scopus) identifier

13. Identification of risk factors for alcohol relapse in liver transplant patients with alcohol-related liver disease

Turan D., GÜNŞAR F., Harputluoglu M., Kabacam G., Gokcan H., Akyildiz M., et al.
JOURNAL OF HEPATOLOGY , cilt.78, 2023 (SCI-Expanded, Scopus) identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 14

1. Nucleos(t)ide analogue cessation outcomes in non-cirrhotic patients with HBeAg-negative chronic hepatitis B

MELEKOĞLU ELLİK Z., ÜNAL F., Koc O., Duman S., Guvenir S. T., YILMAZ V., et al.
European-Association-for-the-Study-of-the-Liver Congress, Amsterdam, Hollanda, 7 - 10 Mayıs 2025, cilt.82, (Özet Bildiri) identifier

2. The impact of tumor budding in patients with hepatocelular carcinoma

Duran o. f., GÖKCAN H., KİREMİTCİ S., YILMAZ V., ÇİFTÇİ A., BODAKÇİ E., et al.
EASL congress 2024, 05 Haziran 2024, (Özet Bildiri)

3. Histological and clinical disease progression in patients with metabolic associated steatotic liver disease using paired biopsy

ekelik m., TURAN D., GÜMÜŞSOY M., KİREMİTCİ S., BODAKÇİ E., yılmaz V., et al.
EASL congress 2024, 05 Haziran 2024, (Özet Bildiri)

4. DISEASE PROGRESSION IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE USING PAIRED LIVER BIOPSY

TURAN GÖKÇE D., Ekelik M. M., Gumussoy M., Kiremitci S., Bodakci E., Yilmaz V., et al.
Digestive Disease Week (DDW), Washington, Kiribati, 18 - 21 Mayıs 2024, cilt.166, (Özet Bildiri) identifier

5. SAT-519 The impact of tumor budding on tumor biology in patients with hepatocellular carcinoma

DURAN O. F., GÖKCAN H., KİREMİTCİ S., GÜVENİR S. T., YILMAZ V., BODAKÇİ E., et al.
AASLD-TASL hepatology connect meeting, 16 Şubat 2024, (Tam Metin Bildiri) identifier

6. Histological and Clinical disease Progression in Patients with Metabolic Dysfuntion associated Steatotic Liver Disease Isinig Paired Biopsy

Ekelik M. M., TURAN D., GÜMÜŞSOY M., KİREMİTCİ S., BODAKÇİ E., YILMAZ V., et al.
AASLD-TASL hepatology connect meeting 2024, 16 Şubat 2024, (Özet Bildiri)

7. The impact of tumor budding on tumor biology in patients with hepatocellular carcinoma

Duran O. F., GÖKCAN H., KİREMİTCİ S., GÜVENİR S. T., YILMAZ V., BODAKÇİ E., et al.
AASLD-TASL hepatology connect meeting 2024, 16 Şubat 2024, (Özet Bildiri) identifier

8. C282Y mutation in hemochromatosis: Single center experience

BODAKÇİ E., GÖKCAN H., GÜMÜŞSOY M., GÜVENİR S. T., YILMAZ V., KARAKAYA M. F., et al.
AASLD-TASL hepatology connect meeting 2024, 16 Şubat 2024, (Özet Bildiri)

9. Case series of C282Y mutation in the HFE gene in Turkey: Single-center experience

BODAKÇİ E., GÖKCAN H., güvener t., YILMAZ V., ER R. E., KARAKAYA M. F., et al.
19. Euroasian Hepatogastroenterology and Surgery, 13 Kasım 2023, (Tam Metin Bildiri)

10. Familial NAFLD Cirrhosis Case Series

AKARCA H. T., GÖKCAN H., GÜVENİR S. T., YILMAZ V., İDİLMAN R.
19. Euroasian Hepatogastroenterology and Surgery, 13 Kasım 2023, (Tam Metin Bildiri)

11. noninvazive fibrosis markers for assesment for liver fibrosis in patients with chronic hepatitis delta

KARAKAYA M. F., KURU ÖZ D., Turan Gökçe D., DUMAN S., Ellik Z. M., GÜMÜŞSOY M., et al.
AASLD 2023 congress, 10 Kasım 2023, (Tam Metin Bildiri)

12. Noninvazive fibrosis markers for assesment for liver fibrosis in patients with chronic hepatitis delta

KARAKAYA M. F., KURU ÖZ D., Turan D., DUMAN S., MELEKOĞLU ELLİK Z., GÜMÜŞSOY M., et al.
AASLD 2023 congress, Amerika Birleşik Devletleri, 10 Kasım 2023, (Özet Bildiri)

13. NON - INVASIVE FIBROSIS MARKERS FOR ASSESMENT OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS DELTA

BODAKÇİ E., KARAKAYA M. F., KURU ÖZ D., Gokce D., DUMAN S., Ellik Z., et al.
Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 10 - 14 Kasım 2023, cilt.78, (Özet Bildiri) identifier

14. Herpes SimplexVirus infection in patients after allogeneic hematopoetic stem cell transplantation

ATİLLA E., ÖZEL F., YILMAZ V., ATACA ATİLLA P., ATEŞAĞAOĞLU B., CİVRİZ BOZDAĞ S., et al.
43rd Annual Meeting Of EBMT, 26 - 29 Mart 2017, (Özet Bildiri)
Kitaplar 1

1. Gebelik ve Diyare

MELEKOĞLU ELLİK Z., YILMAZ V.
Gastroenteroloji ve Gebelik, YÜKSEL MAHMUT, YEŞİL BAYRAM, KÖSEOĞLU HASAN TANKUT, PİRİNÇÇİ SAPMAZ FERDANE, ERÜRKER ÖZTÜRK TUBA, HAMAMCI MEVLÜT, Editör, AKADEMİSYEN KİTABEVİ, Ankara, ss.165-170, 2023
Metrikler

Yayın

28

Yayın (WoS)

17

Yayın (Scopus)

13